[68Ga]Ga-FAPI-46 PET/CT 用于间质性肺病成纤维细胞活化分子评估的潜在价值:单中心先导研究
单中心先导研究纳入20例间质性肺病患者及10例对照,行[68Ga]Ga-FAPI-46 PET/CT与99mTc-MIBI SPECT/CT,并与高分辨率CT(HRCT)和肺功能比较。FAPI与MIBI视觉阳性各12例(60%);HRCT纤维化评分与SUVmean、SUVmax、最大靶/肝比及平均靶/肝比呈显著正相关(P<0.05),FAPI结果与HRCT纤维化评分差异显著(P=0.003)。作者认为两种模态联合对评估纤维化与炎症过程可能有叠加作用。
要点
- 20例间质性肺病患者中FAPI扫描视觉阳性12例(60%),MIBI扫描阳性亦为12例(60%)。
- HRCT纤维化评分与SUVmean、SUVmax、最大靶/肝比及平均靶/肝比呈显著正相关(P<0.05)。
- 20例间质性肺病患者中9例(45%)胆囊见强烈FAPI摄取,对照组10例均无此摄取。
核心结论
- 作者认为[68Ga]Ga-FAPI PET/CT与99mTc-MIBI SPECT/CT联合对评估间质性肺病相关纤维化与炎症过程可能较任一单独模态有叠加作用。
- [68Ga]Ga-FAPI PET/CT似乎有潜力依据HRCT模式判断间质性肺病患者常住成纤维细胞、活化成纤维细胞及瘢痕成熟所反映的纤维化活动水平。
研究设计与样本
- 单中心先导研究,纳入20例间质性肺病患者行[68Ga]Ga-FAPI-46 PET/CT与99mTc-MIBI SPECT/CT,另纳入10例无肺或胸部受累、因肿瘤检测行[68Ga]Ga-FAPI PET/CT者为对照组。
- 图像行视觉与半定量评估,并与HRCT及肺功能检查比较;从肺段得出SUVmax、SUVmean、最大靶/肝比、平均靶/肝比及全肺与各肺叶、肺区总病灶FAPI表达等参数。
- 计算全肺及各肺叶、肺区的最大与平均CT值(HU),并依据HRCT表现定义HRCT纤维化评分(HFS)。
主要发现
- 间质性肺病患者20例平均年龄58.70岁(标准差11.09),对照组10例平均年龄57.70岁(标准差15.19)。
- 视觉评估FAPI扫描阳性12例(60%),MIBI扫描阳性12例(60%);20例中两者均阳性6例、均阴性2例、FAPI阴性而MIBI阳性6例、FAPI阳性而MIBI阴性6例。
- 对照组与间质性肺病组间SUVmax、SUVmean、总病灶FAPI表达、平均靶/肝比、最大HU及平均HU差异显著(P<0.05)。
- 按肺区比较,HFS与SUVmean、SUVmax、最大靶/肝比及平均靶/肝比呈显著正相关(P<0.05)。
- FAPI结果与HFS间差异显著(P=0.003);20例间质性肺病患者中9例(45%)胆囊见强烈FAPI摄取,对照组10例均无。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of the study was to evaluate the association of high-resolution computed tomography (HRCT) findings with pulmonary fibrotic activity in the corresponding regions using [ 68 Ga]Ga-fibroblast activation fibroblast inhibitor (FAPI) PET/CT in patients with interstitial lung disease (ILD). Additionally, the potential of [ 68 Ga]Ga-FAPI-46 PET/CT for evaluating the active fibrosis process and 99m Tc-MIBI scintigraphy for assessing the inflammatory process in ILD patients was also assessed. METHODS: In this pilot study, 20 ILD patients underwent [ 68 Ga]Ga-FAPI-46 PET/CT and 99m Tc-MIBI SPECT/CT. Additionally, 10 patients without lung or thoracic involvement who were undergoing [ 68 Ga]Ga-FAPI PET/CT for cancer detection were enrolled in the control group. The images were evaluated both visually and semiquantitatively and also compared with HRCT and pulmonary function tests. Multiple quantitative parameters were derived from the lung segments in the PET scan, including SUV max , SUV mean , maximum target-to-liver ratio, mean target-to-liver ratio (TLR mean ), and total lesion FAPI expression for the entire lung, as well as its lobes and zones. Additionally, the maximum Hounsfield unit (HU) and mean HU in HRCT were calculated for the whole lung as well as its lobes and zones. Furthermore, an HRCT fibrosis score (HFS) was defined according to the HRCT findings. RESULTS: Twenty ILD patients with a mean age of 58.70 (SD, 11.09) years were enrolled. Additionally, 10 control patients were enrolled with a mean age of 57.70 (SD, 15.19) years. Based on visual assessment, the FAPI scan was positive in 12 (60%) patients. Similarly, the MIBI scan was positive in 12 (60%) patients. In the 20 ILD cases, both scans were positive in 6 cases, and both were negative in 2 cases. Six cases showed FAPI-negative and MIBI-positive results, whereas another 6 cases showed FAPI-positive and MIBI-negative results. Comparing the control and ILD patients, there was a significant difference in SUV max , SUV mean , total lesion FAPI expression, TLR mean , maximum HU, and mean HU ( P < 0.05). When comparing HFS with PET-derived parameters in zones, a significant positive correlation was found between HFS and SUV mean , SUV max , maximum target-to-liver ratio, and TLR mean ( P < 0.05). Additionally, a significant difference was noted between FAPI results and HFS ( P = 0.003). An ancillary finding, 9 of 20 (45%) ILD patients showed intense FAPI uptakes in gallbladder, whereas none of the 10 in the control group showed such uptake. CONCLUSION: The present study may suggest that combining [ 68 Ga]Ga-FAPI PET/CT and 99m Tc-MIBI SPECT/CT yields an additive effect for evaluating ILD-related fibrosis and inflammatory processes over using either modality alone. Furthermore, it appears that [ 68 Ga]Ga-FAPI PET/CT has the potential to ascertain levels of fibrotic activity from population of resident fibroblasts, active fibroblasts, and scar maturation among ILD patients based on their HRCT patterns.
引用
- Bahtouee M, Jafari E, Khazaei M, et al. Exploring the Potential Value of [ 68 Ga]Ga-FAPI-46 PET/CT for Molecular Assessment of Fibroblast Activation in Interstitial Lung Disease : A Single-Center Pilot Study. Clin Nucl Med. 2024. PMID: 39466620. doi:10.1097/RLU.0000000000005505
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。